Pfizer says South African variant could significantly reduce vaccine protection

13 Sept 06:14 Key points summarised by AI

A laboratory study suggests the Pfizer/BioNTech vaccine's antibody protection against the South African variant (B.1.351) could be reduced by two-thirds.
Despite the lab findings, the vaccine still neutralizes the virus, and there is currently no real-world evidence that the variant reduces vaccine protection in people.
Pfizer and BioNTech are preparing to develop an updated version of their mRNA vaccine or a booster shot, should it be required.
Experts believe the vaccine will likely remain protective against severe disease and death from the variant, emphasizing its role in preventing healthcare systems from being overwhelmed.

Sihasak urges Thais in Europe to stay alert as protests spread

Yesterday 12:06 Key points summarised by AI

Thai Foreign Minister Sihasak Phuangketkeow advises Thai nationals in Europe to avoid protest areas and reconsider non-essential travel, citing widespread unrest in countries like France, Italy, and Spain.
The warning comes as demonstrations escalate, with some turning violent, prompting concerns for safety and leading to an emergency Cabinet meeting in Italy and a proposed postponement of diplomatic talks.
Thai embassies and the Department of Consular Affairs issue advisories, urging citizens to monitor local developments, follow official announcements, and register their travel details for assistance, while emphasizing that no Thais have been directly affected yet.